Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 44

1.

The consensus molecular subtypes of colorectal cancer.

Guinney J, Dienstmann R, Wang X, de Reyniès A, Schlicker A, Soneson C, Marisa L, Roepman P, Nyamundanda G, Angelino P, Bot BM, Morris JS, Simon IM, Gerster S, Fessler E, De Sousa E Melo F, Missiaglia E, Ramay H, Barras D, Homicsko K, Maru D, Manyam GC, Broom B, Boige V, Perez-Villamil B, Laderas T, Salazar R, Gray JW, Hanahan D, Tabernero J, Bernards R, Friend SH, Laurent-Puig P, Medema JP, Sadanandam A, Wessels L, Delorenzi M, Kopetz S, Vermeulen L, Tejpar S.

Nat Med. 2015 Nov;21(11):1350-6. doi: 10.1038/nm.3967. Epub 2015 Oct 12.

PMID:
26457759
2.

A Patient-Derived, Pan-Cancer EMT Signature Identifies Global Molecular Alterations and Immune Target Enrichment Following Epithelial-to-Mesenchymal Transition.

Mak MP, Tong P, Diao L, Cardnell RJ, Gibbons DL, William WN, Skoulidis F, Parra ER, Rodriguez-Canales J, Wistuba II, Heymach JV, Weinstein JN, Coombes KR, Wang J, Byers LA.

Clin Cancer Res. 2016 Feb 1;22(3):609-20. doi: 10.1158/1078-0432.CCR-15-0876. Epub 2015 Sep 29.

PMID:
26420858
3.

Genetics, diagnosis and management of colorectal cancer (Review).

De Rosa M, Pace U, Rega D, Costabile V, Duraturo F, Izzo P, Delrio P.

Oncol Rep. 2015 Sep;34(3):1087-96. doi: 10.3892/or.2015.4108. Epub 2015 Jul 3.

4.

Stemness of the hybrid Epithelial/Mesenchymal State in Breast Cancer and Its Association with Poor Survival.

Grosse-Wilde A, Fouquier d'Hérouël A, McIntosh E, Ertaylan G, Skupin A, Kuestner RE, del Sol A, Walters KA, Huang S.

PLoS One. 2015 May 28;10(5):e0126522. doi: 10.1371/journal.pone.0126522. eCollection 2015.

5.
6.

Altered pathways and colorectal cancer prognosis.

Moreno V, Sanz-Pamplona R.

BMC Med. 2015 Apr 8;13:76. doi: 10.1186/s12916-015-0307-6.

7.

Lithium chloride induces mesenchymal‑to‑epithelial reverting transition in primary colon cancer cell cultures.

Costabile V, Duraturo F, Delrio P, Rega D, Pace U, Liccardo R, Rossi GB, Genesio R, Nitsch L, Izzo P, De Rosa M.

Int J Oncol. 2015 May;46(5):1913-23. doi: 10.3892/ijo.2015.2911. Epub 2015 Mar 2.

8.

Implications of epithelial-mesenchymal plasticity for heterogeneity in colorectal cancer.

Pereira L, Mariadason JM, Hannan RD, Dhillon AS.

Front Oncol. 2015 Feb 2;5:13. doi: 10.3389/fonc.2015.00013. eCollection 2015. Review.

9.

USP11-dependent selective cIAP2 deubiquitylation and stabilization determine sensitivity to Smac mimetics.

Lee EW, Seong D, Seo J, Jeong M, Lee HK, Song J.

Cell Death Differ. 2015 Sep;22(9):1463-76. doi: 10.1038/cdd.2014.234. Epub 2015 Jan 23.

PMID:
25613375
10.

STIM1, a direct target of microRNA-185, promotes tumor metastasis and is associated with poor prognosis in colorectal cancer.

Zhang Z, Liu X, Feng B, Liu N, Wu Q, Han Y, Nie Y, Wu K, Shi Y, Fan D.

Oncogene. 2015 Sep 10;34(37):4808-20. doi: 10.1038/onc.2014.404. Epub 2014 Dec 22.

11.

Evaluation and validation of a robust single cell RNA-amplification protocol through transcriptional profiling of enriched lung cancer initiating cells.

Rothwell DG, Li Y, Ayub M, Tate C, Newton G, Hey Y, Carter L, Faulkner S, Moro M, Pepper S, Miller C, Blackhall F, Bertolini G, Roz L, Dive C, Brady G.

BMC Genomics. 2014 Dec 17;15:1129. doi: 10.1186/1471-2164-15-1129.

12.

How Can Next-Generation Sequencing (Genomics) Help Us in Treating Colorectal Cancer?

Ciombor KK, Haraldsdottir S, Goldberg RM.

Curr Colorectal Cancer Rep. 2014 Dec 1;10(4):372-379.

13.

Nuclear factor of activated T-cell activity is associated with metastatic capacity in colon cancer.

Tripathi MK, Deane NG, Zhu J, An H, Mima S, Wang X, Padmanabhan S, Shi Z, Prodduturi N, Ciombor KK, Chen X, Washington MK, Zhang B, Beauchamp RD.

Cancer Res. 2014 Dec 1;74(23):6947-57. doi: 10.1158/0008-5472.CAN-14-1592. Epub 2014 Oct 15.

14.

Epigenetic mechanisms underlying the dynamic expression of cancer-testis genes, PAGE2, -2B and SPANX-B, during mesenchymal-to-epithelial transition.

Yilmaz-Ozcan S, Sade A, Kucukkaraduman B, Kaygusuz Y, Senses KM, Banerjee S, Gure AO.

PLoS One. 2014 Sep 17;9(9):e107905. doi: 10.1371/journal.pone.0107905. eCollection 2014.

15.

Epithelial-mesenchymal transition spectrum quantification and its efficacy in deciphering survival and drug responses of cancer patients.

Tan TZ, Miow QH, Miki Y, Noda T, Mori S, Huang RY, Thiery JP.

EMBO Mol Med. 2014 Sep 11;6(10):1279-93. doi: 10.15252/emmm.201404208.

16.

Proteogenomic characterization of human colon and rectal cancer.

Zhang B, Wang J, Wang X, Zhu J, Liu Q, Shi Z, Chambers MC, Zimmerman LJ, Shaddox KF, Kim S, Davies SR, Wang S, Wang P, Kinsinger CR, Rivers RC, Rodriguez H, Townsend RR, Ellis MJ, Carr SA, Tabb DL, Coffey RJ, Slebos RJ, Liebler DC; NCI CPTAC.

Nature. 2014 Sep 18;513(7518):382-7. doi: 10.1038/nature13438. Epub 2014 Jul 20.

17.

Molecular genetics of colorectal cancer.

Bogaert J, Prenen H.

Ann Gastroenterol. 2014;27(1):9-14. Review.

18.

Widespread FRA1-dependent control of mesenchymal transdifferentiation programs in colorectal cancer cells.

Diesch J, Sanij E, Gilan O, Love C, Tran H, Fleming NI, Ellul J, Amalia M, Haviv I, Pearson RB, Tulchinsky E, Mariadason JM, Sieber OM, Hannan RD, Dhillon AS.

PLoS One. 2014 Mar 21;9(3):e88950. doi: 10.1371/journal.pone.0088950. eCollection 2014.

19.

TAp63 suppress metastasis via miR-133b in colon cancer cells.

Lin CW, Li XR, Zhang Y, Hu G, Guo YH, Zhou JY, Du J, Lv L, Gao K, Zhang Y, Deng H.

Br J Cancer. 2014 Apr 29;110(9):2310-20. doi: 10.1038/bjc.2014.118. Epub 2014 Mar 4.

20.

Intestinal stem cells and the colorectal cancer microenvironment.

Ong BA, Vega KJ, Houchen CW.

World J Gastroenterol. 2014 Feb 28;20(8):1898-909. doi: 10.3748/wjg.v20.i8.1898. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk